NM_012168.6(FBXO2):c.322G>T (p.Asp108Tyr) AND not specified
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Mar 1, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004280659.1
Allele description [Variation Report for NM_012168.6(FBXO2):c.322G>T (p.Asp108Tyr)]
NM_012168.6(FBXO2):c.322G>T (p.Asp108Tyr)
Condition(s)
- Synonyms:
- AllHighlyPenetrant
- Identifiers:
- MedGen: CN169374
-
Osmolar modulation drives reversible cell cycle exit and human pluripotent cell ...
Osmolar modulation drives reversible cell cycle exit and human pluripotent cell differentiation via NF-κВ and WNT signalingOsmolar modulation drives reversible cell cycle exit and human pluripotent cell differentiation via NF-κВ and WNT signalingBioProject
-
377.small ve, Cyrillic (1)
BioProject
-
Mus musculus histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA
Mus musculus histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNAgi|31981715|ref|NM_010378.2|Nucleotide
-
Malassezia globosa CBS 7966 uncharacterized protein (MGL_0608), partial mRNA
Malassezia globosa CBS 7966 uncharacterized protein (MGL_0608), partial mRNAgi|164663422|ref|XM_001732781.1|Nucleotide
-
Gm22879 predicted gene, 22879 [Mus musculus]
Gm22879 predicted gene, 22879 [Mus musculus]Gene ID:115489587Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 13, 2024